Cignas 2026 commercial formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
Our group has previously published that the scaffolding LSD1 inhibitor SP-2509 and its clinical successor SP-2577, or seclidemstat, potently suppress the viability and metabolism of NK cells (7)
It was approved in 2023 for geographic atrophy (GA) secondary to AMD, but its current label only recommends treatment for up to 12 months
The limited supplies currently experienced by patients with diabetes are not purely a function of supply and demand, but also who doctors are prescribing the drugs to
AOD 9604 does not cause fluid retention
Thyroid test Everlywells Thyroid Test ($149) evaluates thyroid function through the analysis of three thyroid hormones thyroid-stimulating hormone (TSH), T3, and T4 and thyroid peroxidase antibodies
